The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic portfolio management to optimize resource allocation and enhance competitive advantage.
Mehtap Saydam Aydemir
Advertisement
Articles by Mehtap Saydam Aydemir
Advertisement
Latest Updated Articles
Applying Porter’s Five Forces to Portfolio Management in Pharmaceutical R&D: A Strategic RoadmapPublished: March 17th 2025 | Updated:
Advertisement
Advertisement
